Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
6.22
+0.13 (2.13%)
At close: Nov 26, 2025, 4:00 PM EST
6.20
-0.02 (-0.29%)
After-hours: Nov 26, 2025, 7:59 PM EST

Aquestive Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
43.457.5650.5847.6850.8345.85
Upgrade
Revenue Growth (YoY)
-26.32%13.79%6.09%-6.20%10.87%-12.85%
Upgrade
Cost of Revenue
17.2417.8720.8319.3914.9912.96
Upgrade
Gross Profit
26.1639.6929.7528.2935.8432.89
Upgrade
Selling, General & Admin
63.0450.1831.7552.8853.4855.89
Upgrade
Research & Development
18.9120.2813.117.4817.0519.89
Upgrade
Operating Expenses
81.9570.4644.8570.3670.5275.78
Upgrade
Operating Income
-55.79-30.77-15.1-42.07-34.68-42.89
Upgrade
Interest Expense
-17.05-16.82-7.46-12.44-22.46-13.02
Upgrade
Interest & Investment Income
5.053.141.820.10.420.13
Upgrade
Other Non Operating Income (Expenses)
--6---
Upgrade
EBT Excluding Unusual Items
-67.79-44.45-14.74-54.41-56.72-55.78
Upgrade
Legal Settlements
--8.5---
Upgrade
Other Unusual Items
-1.20.3-1.38--13.82-
Upgrade
Pretax Income
-68.99-44.15-7.63-54.41-70.54-55.78
Upgrade
Income Tax Expense
-0.01-0.010.25---
Upgrade
Net Income
-68.98-44.14-7.87-54.41-70.54-55.78
Upgrade
Net Income to Common
-68.98-44.14-7.87-54.41-70.54-55.78
Upgrade
Shares Outstanding (Basic)
998761493834
Upgrade
Shares Outstanding (Diluted)
998761493834
Upgrade
Shares Change (YoY)
22.87%41.58%25.69%27.99%13.15%32.71%
Upgrade
EPS (Basic)
-0.70-0.51-0.13-1.12-1.85-1.66
Upgrade
EPS (Diluted)
-0.70-0.51-0.13-1.12-1.85-1.66
Upgrade
Free Cash Flow
-50.94-35.92-7.38-10.84-33.89-45.98
Upgrade
Free Cash Flow Per Share
-0.51-0.41-0.12-0.22-0.89-1.37
Upgrade
Gross Margin
60.28%68.95%58.82%59.34%70.51%71.73%
Upgrade
Operating Margin
-128.56%-53.46%-29.86%-88.23%-68.22%-93.55%
Upgrade
Profit Margin
-158.95%-76.68%-15.56%-114.12%-138.77%-121.67%
Upgrade
Free Cash Flow Margin
-117.39%-62.40%-14.58%-22.74%-66.67%-100.28%
Upgrade
EBITDA
-55.2-30.03-13.73-39.51-31.53-39.29
Upgrade
EBITDA Margin
-127.20%-52.17%-27.14%-82.87%-62.02%-85.68%
Upgrade
D&A For EBITDA
0.590.741.372.553.153.61
Upgrade
EBIT
-55.79-30.77-15.1-42.07-34.68-42.89
Upgrade
EBIT Margin
-128.56%-53.46%-29.86%-88.23%-68.22%-93.55%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q